https://www.efda.gov.et/notice/description-for-inclusion-of-tramadol-in-nps-list/2022-10-21T19:14:00+00:00https://www.efda.gov.et/notice/efda-regulation-for-comment/2022-11-10T07:26:54+00:00https://www.efda.gov.et/notice/invitation-for-stakeholders-webinar-conference-to-boost-product-marketing-authorization/2023-01-09T07:32:22+00:00https://www.efda.gov.et/notice/letter-to-market-authorization-holders-announcement-21-6-2023/2023-06-22T07:18:13+00:00https://www.efda.gov.et/notice/fortified-foods-and-fortificants-control-directive-for-comment/2023-08-24T08:34:44+00:00https://www.efda.gov.et/notice/to-all-market-authorization-holders/2023-09-14T06:48:51+00:00https://www.efda.gov.et/notice/radiopharmaceuticals-registration-notification/2024-02-05T07:32:19+00:00https://www.efda.gov.et/notice/medical-gas-registration-request-notification/2024-02-05T07:40:05+00:00https://www.efda.gov.et/notice/%e1%89%a0%e1%88%a8%e1%89%82%e1%89%85-%e1%88%95%e1%8c%8d-%e1%88%8b%e1%8b%ad-%e1%8a%a0%e1%88%b5%e1%89%b0%e1%8b%ab%e1%8b%a8%e1%89%b5-%e1%8a%a5%e1%8a%95%e1%8b%b2%e1%88%b0%e1%8c%a5-%e1%8b%a8%e1%89%80/2024-03-29T09:11:41+00:00https://www.efda.gov.et/notice/ethiopian-national-essential-medicine-list-for-comment/2024-05-31T11:34:42+00:00https://www.efda.gov.et/notice/medical-product-alert-01-2024-public-alert-notice-on-counterfeited-herceptin-440mg/2024-07-14T08:32:39+00:00https://www.efda.gov.et/notice/%e1%89%a0%e1%88%a8%e1%89%82%e1%89%85-%e1%88%85%e1%8c%8d-%e1%88%8b%e1%8b%ad-%e1%8a%a0%e1%88%b5%e1%89%b0%e1%8b%ab%e1%8b%a8%e1%89%b5-%e1%8a%a5%e1%8a%95%e1%8b%b2%e1%88%b0%e1%8c%a5-%e1%8b%a8%e1%89%a3/2024-10-02T06:21:50+00:00https://www.efda.gov.et/notice/ethiopian-medicine-formulary-3rd-edition-draft-october-10-2024-for-comment/2024-10-17T11:39:07+00:00https://www.efda.gov.et/notice/%e1%89%a0%e1%88%a8%e1%89%82%e1%89%85-%e1%88%85%e1%8c%8d-%e1%88%8b%e1%8b%ad-%e1%8a%a0%e1%88%b5%e1%89%b0%e1%8b%ab%e1%8b%a8%e1%89%b5-%e1%8a%a5%e1%8a%95%e1%8b%b2%e1%88%b0%e1%8c%a5/2025-01-06T07:19:01+00:00https://www.efda.gov.et/notice/notification-for-submission-of-bioevalence-study-reports-as-mandatory-requirement/2025-02-12T06:56:26+00:00https://www.efda.gov.et/notice/%e1%89%a0%e1%88%a8%e1%89%82%e1%89%85-%e1%88%85%e1%8c%8d-%e1%88%8b%e1%8b%ad-%e1%8a%a0%e1%88%b5%e1%89%b0%e1%8b%ab%e1%8b%a8%e1%89%b5-%e1%8a%a5%e1%8a%95%e1%8b%b2%e1%88%b0%e1%8c%a5-2/2025-05-15T17:57:44+00:00https://www.efda.gov.et/notice/official-letter-clarification-on-amendment-of-renewal-processing/2025-09-15T13:53:31+00:00https://www.efda.gov.et/notice/to-all-market-authorization-holders-mahs/2025-10-10T13:33:06+00:00https://www.efda.gov.et/notice/12421/2025-10-17T07:48:37+00:00https://www.efda.gov.et/notice/subject-second-call-for-completing-registration-in-the-rfda-mvc-traceability-hub/2026-02-17T07:30:28+00:00